Researchers in China have confirmed that BBIBP-CorV, a vaccine currently under observation in human trials, has safely triggered the expected antibody immune responses. The combined early and mid-stage trials of the vaccine were conducted between April 29 and July 30 of this year. The Beijing Institute of Biological Products, a …
Read More »China’s Covid-19 Vaccine Candidate Vaccine Proves Safe in Initial Testing
